Oxytocin And Uterotonic Agent Use For Cesarean Delivery

Completed · Phase 4

Conditions studied: Uterine Atony, Hypotension

In brief

The central objective of this study will be to evaluate a standardized, evidence-based regimen versus a conventional regimen for uterotonic drug dosing for elective cesarean delivery The investigators primary hypothesis is that the proposed uterotonic drug regimen, when compared to conventional dosing regimen, during elective cesarean delivery will: 1\. Reduce the overall amount of oxytocin and other uterotonic agents used to obtain satisfactory uterine tone. Secondary outcomes to be evaluated will be: 1. Reduce the side effects associated with uterotonic drug use 2. Reduce the time to establishment and maintenance of adequate uterine tone

Key facts

Study ID

NCT01549223

Run by

Brigham and Women's Hospital

People needed

60

Starts

2011-04-01

Expected to finish

2012-01-01

Last updated by the study team

2017-06-29

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• American Society of Anesthesiologists (ASA) I or II health status
• Age between 18 and 50 yrs
• Singleton pregnancies in vertex position
• Elective (without prior labor) cesarean delivery with a planned lower uterine (pfannenstiel) incision

You may not qualify if…

• Conditions that predispose to uterine atony and postpartum hemorrhage

Where it is running

• Brigham and Women's Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.